In 2025, an oral version, known as the Wegovy pill, gained FDA approval, catering to those who prefer an oral intake
Right upper quadrant pain, especially if accompanied by fever, jaundice (yellowing of the skin/eyes), or dark urine, may indicate gallbladder disease, which has been associated with GLP-1 receptor agonists and rapid weight loss
It should not be converted directly into a KLOW protocol
Nat Metab 3(2):258273 Richards J et al (2023) Successful treatment of binge eating disorder with the GLP-1 agonist semaglutide: a retrospective cohort study
one Published Research The SURMOUNT and SURPASS trial programs provide extensive published documentation: SURMOUNT-1 through SURMOUNT-4: Obesity indication trials SURPASS-1 through SURPASS-5: Diabetes indication trials Extensive real-world evidence from post-marketing surveillance Published literature across multiple populations and demographics Retatrutide: GLP-1 + GIP + Glucagon Retatrutide represents the most comprehensive receptor coverage, activating all three pathways that Mazdutide and Tirzepatide divide between them
Further in vitro and in vivo studies, including experimental models, are needed to clarify the mechanistic roles of these molecular effectors and to validate their contribution to the Long COVID phenotype
